• 1. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

Introduction to 1-(2-bromophenyl)-1H-pyrazol-4-amine (CAS No. 1153039-45-2)

1-(2-bromophenyl)-1H-pyrazol-4-amine, with the CAS number 1153039-45-2, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a brominated phenyl group and a pyrazole ring, making it a valuable scaffold for the development of novel therapeutic agents.

The chemical structure of 1-(2-bromophenyl)-1H-pyrazol-4-amine consists of a pyrazole ring attached to a 2-bromophenyl group through a single bond. The presence of the bromine atom on the phenyl ring imparts specific electronic and steric properties to the molecule, which can influence its biological activity and reactivity. The amine group on the pyrazole ring further enhances its potential for forming hydrogen bonds, which is crucial for interactions with biological targets.

In recent years, 1-(2-bromophenyl)-1H-pyrazol-4-amine has been extensively studied for its potential applications in drug discovery and development. One of the key areas of interest is its role as a scaffold for the design of inhibitors targeting various enzymes and receptors. For instance, researchers have explored its use in developing inhibitors for kinases, which are important targets in cancer therapy. The bromine substituent on the phenyl ring can enhance the binding affinity of these inhibitors to their target proteins, thereby improving their efficacy.

Beyond kinase inhibition, 1-(2-bromophenyl)-1H-pyrazol-4-amine has also shown promise in modulating other biological processes. Studies have demonstrated its potential as an anti-inflammatory agent, with some derivatives exhibiting potent inhibitory effects on pro-inflammatory cytokines such as TNF-α and IL-6. This makes it a potential candidate for treating inflammatory diseases such as rheumatoid arthritis and Crohn's disease.

The synthetic accessibility of 1-(2-bromophenyl)-1H-pyrazol-4-amine is another factor that contributes to its appeal in pharmaceutical research. Various synthetic routes have been developed to efficiently produce this compound, allowing for the rapid generation of structurally diverse derivatives. These synthetic methods often involve palladium-catalyzed cross-coupling reactions, which are well-established techniques in organic synthesis.

In addition to its therapeutic potential, 1-(2-bromophenyl)-1H-pyrazol-4-amine has also been investigated for its use in diagnostic imaging. Some derivatives of this compound have been labeled with radioisotopes or fluorescent tags, enabling their use as imaging agents in techniques such as positron emission tomography (PET) and fluorescence imaging. These applications highlight the versatility of the compound and its potential to contribute to both therapeutic and diagnostic advancements.

The pharmacokinetic properties of 1-(2-bromophenyl)-1H-pyrazol-4-amine have also been studied to understand its behavior in biological systems. Research has shown that it exhibits favorable solubility and permeability characteristics, which are essential for oral bioavailability and distribution to target tissues. However, further optimization may be required to enhance these properties for specific therapeutic applications.

In conclusion, 1-(2-bromophenyl)-1H-pyrazol-4-amine (CAS No. 1153039-45-2) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features, synthetic accessibility, and favorable pharmacokinetic properties make it an attractive scaffold for the development of novel therapeutic agents targeting various diseases. Ongoing research continues to uncover new possibilities for this versatile compound, underscoring its significance in modern drug discovery efforts.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)